Statistics

Total Visits

Views
NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma-R0 resection, pCR, and toxicity analysis66

Select a period of time:

Number of views in the range

Views
NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma-R0 resection, pCR, and toxicity analysis35

Views

Views
May 20255
June 20256
July 20258
August 20250
September 20257
October 20255
November 20254
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore11
United States10
United Kingdom5
Brazil2
Argentina2
Barbados1
Egypt1
Ethiopia1
France1
Mexico1
 

Top cities views

Views
Dallas6
Aberdeen1
Beaumont1
Bridgetown1
Cairo1
Fortaleza1
Jimma1
José C. Paz1
Liverpool1
Lytham St Annes1